CTLA4 and melanoma: Pepple’s study also detected strong immune-enhancing responses in mouse melanoma and hepatocellular carcinoma models after administration of anti-CTLA-4, followed by mechanical ablation the next day, and two subsequent anti-CTLA-4 treatments (92).